Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pegfilgrastim +/- ciprofloxacin for primary prophylaxis with TAC (docetaxel/doxorubicin/cyclophosphamide) chemotherapy for breast cancer. Results from the GEPARTRIO study.
von Minckwitz G, Kümmel S, du Bois A, Eiermann W, Eidtmann H, Gerber B, Hilfrich J, Huober J, Costa SD, Jackisch C, Grasshoff ST, Vescia S, Skacel T, Loibl S, Mehta KM, Kaufmann M; German Breast Group. von Minckwitz G, et al. Among authors: vescia s. Ann Oncol. 2008 Feb;19(2):292-8. doi: 10.1093/annonc/mdm438. Epub 2007 Sep 9. Ann Oncol. 2008. PMID: 17846019 Free article. Clinical Trial.
CMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: a randomised trial (GABG trial IV-A-93).
von Minckwitz G, Graf E, Geberth M, Eiermann W, Jonat W, Conrad B, Brunnert K, Gerber B, Vescia S, Wollert J, Kaufmann M. von Minckwitz G, et al. Among authors: vescia s. Eur J Cancer. 2006 Aug;42(12):1780-8. doi: 10.1016/j.ejca.2006.04.006. Epub 2006 Jun 12. Eur J Cancer. 2006. PMID: 16765589 Clinical Trial.
The GISS trial: a phase II prevention trial of screening plus goserelin, ibandronate, versus screening alone in premenopausal women at increased risk of breast cancer.
von Minckwitz G, Loibl S, Jackisch C, Paepke S, Nestle-Kraemling C, Lux MP, Maass N, Schmutzler R, du Bois A, Wallwiener D, Vescia S, Budischewski K, Kaufmann M. von Minckwitz G, et al. Among authors: vescia s. Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2141-9. doi: 10.1158/1055-9965.EPI-11-0222. Epub 2011 Jul 27. Cancer Epidemiol Biomarkers Prev. 2011. PMID: 21795500 Clinical Trial.
A randomised trial of goserelin versus control after adjuvant, risk-adapted chemotherapy in premenopausal patients with primary breast cancer - GABG-IV B-93.
Kaufmann M, Graf E, Jonat W, Eiermann W, Vescia S, Geberth M, Conrad B, Gademann G, Albert US, Loibl S, von Minckwitz G, Schumacher M; German Adjuvant Breast Cancer Study Group (GABG). Kaufmann M, et al. Among authors: vescia s. Eur J Cancer. 2007 Nov;43(16):2351-8. doi: 10.1016/j.ejca.2007.08.012. Epub 2007 Sep 25. Eur J Cancer. 2007. PMID: 17897821 Clinical Trial.
Dose-intensified epirubicin versus standard-dose epirubicin/cyclophosphamide followed by CMF in breast cancer patients with 10 or more positive lymph nodes: results of a randomised trial (GABG-IV E-93) - the German Adjuvant Breast Cancer Group.
Eiermann W, Graf E, Ataseven B, Conrad B, Hilfrich J, Massinger-Biebl H, Vescia S, Loibl S, von Minckwitz G, Schumacher M, Kaufmann M; German Adjuvant Breast Cancer Group. Eiermann W, et al. Among authors: vescia s. Eur J Cancer. 2010 Jan;46(1):84-94. doi: 10.1016/j.ejca.2009.10.001. Eur J Cancer. 2010. PMID: 19879750 Clinical Trial.
Identification of trains of sleep sequences in adult rats.
Piscopo S, Mandile P, Montagnese P, Cotugno M, Giuditta A, Vescia S. Piscopo S, et al. Among authors: vescia s. Behav Brain Res. 2001 Feb 15;119(1):93-101. doi: 10.1016/s0166-4328(00)00339-9. Behav Brain Res. 2001. PMID: 11164530
21 results